Home›CARDIOVASCULAR›PCSK9 Inhibitors (Evolocumab, Inclisiran)

PCSK9 Inhibitors (Evolocumab, Inclisiran)

Evidence: ★★★★★ · Status: FDA Approved

💡 Did you know? PCSK9-inhibitor cholesterol drugs came from studying rare people born with a gene mutation that gave them very low LDL and almost no heart disease.

In plain English

LDL receptors are the vacuum cleaners that remove bad cholesterol; PCSK9 destroys them. Block PCSK9 and the vacuums keep working — dropping LDL dramatically. Inclisiran is a gene-silencing shot given just twice a year.

How it works

Block PCSK9, the protein that degrades LDL receptors — so LDL receptors survive longer and clear far more LDL. Inclisiran is an siRNA silencing PCSK9, dosed twice yearly.

Molecular target & official sources

PCSK9 (NCBI Gene) · Evolocumab (DrugBank)

Bottom line

Most powerful LDL-lowering available; the siRNA form is a genuine leap.

Helps with: Cardiovascular

Availability & where to buy

Available over the counter. Widely available OTC — e.g. iHerb (ships worldwide); in Singapore also Guardian, Watsons, GNC, Shopee / Lazada. Look for a third-party-tested / GMP mark and check the dose per serving.

Compare PCSK9 Inhibitors (Evolocumab, Inclisiran)

Common questions

Does PCSK9 Inhibitors (Evolocumab, Inclisiran) actually work?

Human-evidence rating: 5 of 5. Most powerful LDL-lowering available; the siRNA form is a genuine leap.

Is PCSK9 Inhibitors (Evolocumab, Inclisiran) legal or approved?

Regulatory status: FDA Approved.